Why ImmunityBio Stock Slumped on Monday
The Big Market Report Take
The FDA isn't happy about how the biotech wanted to promote its cancer drug.
Not financial advice. The Big Market Report aggregates news for informational purposes only. Nothing on this site constitutes investment advice. Equities and other securities are subject to market risk. Always do your own research and consult a qualified financial advisor before making any investment decisions. Full disclaimer →
Never miss a story
More from this section
- Assertio: Why I'm Selling The Rally (Rating Downgrade)Seeking Alpha48m ago
- Employment Report: 178K Jobs Added In March, Better Than ExpectedSeeking Alpha58m ago
- CFR's Ewers: US and Iran Far From a DealBloomberg Markets1h ago
Is Valero Energy One of the Best Oil Stocks to Buy Right Now?The Motley Fool1h ago- Trump Threatens Destruction in Iran, Demands Hormuz OpenBloomberg Markets1h ago